Haemonetics (HAE) Accumulated Expenses (2010 - 2026)

Haemonetics has reported Accumulated Expenses for 17 years, with the latest figure at $38.1 million in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 6.54% year-over-year to $38.1 million in Q2 2026; TTM through Jun 2026 was $38.1 million, a 6.54% increase from a year earlier, with the FY2026 full-year figure at $68.2 million, up 14.76% from the prior year.
• Accumulated Expenses was $38.1 million for Q2 2026 at Haemonetics, down from $68.2 million in the prior quarter.
• The five-year high for Accumulated Expenses was $80.7 million in Q1 2024, with the low at $30.4 million in Q3 2022.
• Average Accumulated Expenses over 5 years is $49.2 million, with a median of $48.3 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses surged 33.64% in 2022, then retreated 26.37% in 2025.
• Over 5 years, Accumulated Expenses stood at $52.2 million in 2022, then climbed by 12.61% to $58.8 million in 2023, then slipped by 21.83% to $45.9 million in 2024, then gained by 13.42% to $52.1 million in 2025, then decreased by 26.78% to $38.1 million in 2026.
• The last three Accumulated Expenses figures came in at $38.1 million (Q2 2026), $68.2 million (Q1 2026), and $52.1 million (Q4 2025), per Business Quant data.